EP1575359A4 - Reduction d'especes reactives d'oxygene dans le traitement de plaies chroniques - Google Patents

Reduction d'especes reactives d'oxygene dans le traitement de plaies chroniques

Info

Publication number
EP1575359A4
EP1575359A4 EP03808544A EP03808544A EP1575359A4 EP 1575359 A4 EP1575359 A4 EP 1575359A4 EP 03808544 A EP03808544 A EP 03808544A EP 03808544 A EP03808544 A EP 03808544A EP 1575359 A4 EP1575359 A4 EP 1575359A4
Authority
EP
European Patent Office
Prior art keywords
reduction
oxygen species
reactive oxygen
chronic wound
wound management
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03808544A
Other languages
German (de)
English (en)
Other versions
EP1575359A1 (fr
Inventor
Stephen H Monroe
Hans Hoekstra
Den Berg A J J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Publication of EP1575359A1 publication Critical patent/EP1575359A1/fr
Publication of EP1575359A4 publication Critical patent/EP1575359A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
EP03808544A 2002-12-23 2003-12-23 Reduction d'especes reactives d'oxygene dans le traitement de plaies chroniques Withdrawn EP1575359A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
US436197P 2002-12-23
PCT/US2003/041038 WO2004057965A1 (fr) 2002-12-23 2003-12-23 Reduction d'especes reactives d'oxygene dans le traitement de plaies chroniques

Publications (2)

Publication Number Publication Date
EP1575359A1 EP1575359A1 (fr) 2005-09-21
EP1575359A4 true EP1575359A4 (fr) 2009-08-05

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03808544A Withdrawn EP1575359A4 (fr) 2002-12-23 2003-12-23 Reduction d'especes reactives d'oxygene dans le traitement de plaies chroniques

Country Status (6)

Country Link
EP (1) EP1575359A4 (fr)
JP (1) JP2006511585A (fr)
CN (1) CN1744819A (fr)
AU (1) AU2003303335A1 (fr)
CA (1) CA2511440A1 (fr)
WO (1) WO2004057965A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201608068SA (en) * 2008-04-01 2016-11-29 Antipodean Pharmaceuticals Inc Compositions And Methods For Skin Care
AU2010286318A1 (en) * 2009-08-24 2012-04-05 Wound Management Pty Ltd Purine-targeted diagnosis and therapy of wounds
JP6133858B2 (ja) * 2011-07-28 2017-05-24 スリーエム イノベイティブ プロパティズ カンパニー 創傷治癒組成物及び使用方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777A1 (de) * 1984-05-07 1985-11-07 Gödecke AG, 1000 Berlin Pharmazeutische topische zubereitungen, verfahren zu deren herstellung und deren verwendung zur foerderung der wundgranulation und epithelisation
WO2003045366A1 (fr) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Traitement de plaies et compositions utilisees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3640215B2 (ja) * 1992-11-06 2005-04-20 グレイストーン・メディカル・グループ・インコーポレイテッド オーク樹皮抽出物の組成物、関連する合成組成物およびこれを用いる方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416777A1 (de) * 1984-05-07 1985-11-07 Gödecke AG, 1000 Berlin Pharmazeutische topische zubereitungen, verfahren zu deren herstellung und deren verwendung zur foerderung der wundgranulation und epithelisation
WO2003045366A1 (fr) * 2001-11-29 2003-06-05 Greystone Medical Group, Inc. Traitement de plaies et compositions utilisees

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANDREWS M ET AL: "The role of zinc in wound healing", ADVANCES IN WOUND CARE : THE JOURNAL FOR PREVENTION AND HEALING,, vol. 12, no. 3, 1 April 1999 (1999-04-01), pages 137 - 138, XP009112199, ISSN: 1076-2191 *
See also references of WO2004057965A1 *

Also Published As

Publication number Publication date
WO2004057965A1 (fr) 2004-07-15
EP1575359A1 (fr) 2005-09-21
AU2003303335A1 (en) 2004-07-22
CA2511440A1 (fr) 2004-07-15
JP2006511585A (ja) 2006-04-06
CN1744819A (zh) 2006-03-08

Similar Documents

Publication Publication Date Title
AU2003286597A8 (en) Biosensor having hematocrit and oxygen biases
EP1802214B8 (fr) Contenant compact pourvu d'une structure de boitier a contenu pouvant etre inseree et extraite par glissement
AU2003294368A8 (en) Wound dressing
EP1813388A4 (fr) Bande de polissage et procédé de polissage
EP1680761A4 (fr) Droits statiques ou dynamiques et limites ou permanents relatifs a des contenus
GB2388046B (en) Gaming apparatus with power saving feature
GB0324429D0 (en) Improvements in and relating to gaming systems
AU2003301154A8 (en) Methods for managing a pool of multicast addresses and allocating addresses in a communications system
EP1481703A4 (fr) Enrichisseur d'oxygene
GB0215023D0 (en) Wound dressing
EP1472079A4 (fr) Ruban de carbone blanc seche par rayonnement
EP1575359A4 (fr) Reduction d'especes reactives d'oxygene dans le traitement de plaies chroniques
AU2003207503A1 (en) Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
AU2003295178A1 (en) Sinusoid selection in audio encoding
AU2003234599A1 (en) Methods and compounds for reducing biofilm formation
GB0224832D0 (en) Improvements in and relating to filters
GB0226436D0 (en) Improvements in and relating to catheter control
AU2003276636A1 (en) Sinusoid selection in audio encoding
GB0217220D0 (en) Improvements in and relating to tape measures
AU2003203237A1 (en) Structure of skylight in greenhouse
GB0224180D0 (en) Improved oxygen storage component
AU2003252693A1 (en) Factor participating in transcriptional regulation
GB0213402D0 (en) Improvements in coated equipment
AU2003302389A8 (en) Modification of drawn films
GB2388994B (en) Improvements in and relating to sound emitting devices

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050630

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1081074

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20090706

17Q First examination report despatched

Effective date: 20110218

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110629

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1081074

Country of ref document: HK